Shanghai Pharmaceuticals (02607.HK): Shanghai Shangshi Yangtze River will transfer its 40% equity in Shanghai Pharmaceuticals Group to Shanghai Shangshi.

Zhixin Finance APP News, Shanghai Pharmaceutical (02607.HK) announced that the company received a "Brief Equity Change Report" from Shanghai Shangshi Yangtze River Delta Ecological Development Co., Ltd. (Shanghai Shangshi Yangtze River Delta) on September 24, 2025. Shanghai Shangshi Yangtze River Delta and Shanghai Shangshi (Group) Co., Ltd. (Shanghai Shangshi) signed a "Equity Transfer Agreement" on September 24, 2025. Shanghai Shangshi Yangtze River Delta will transfer 40% of its equity in Shanghai Pharmaceutical (Group) Co., Ltd. (Shang Pharm Group) to Shanghai Shangshi, with a total transfer price of 6.722 billion yuan.